SLN12140 in Adult Participants With IgA Nephropathy in China
NCT07553494
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
IgA Nephropathy (IgAN)
Interventions
DRUG:
SLN12140
OTHER:
Placebo
Sponsor
Linno Pharmaceuticals, Inc.